NATALYA CSATARI: Open Payments
NPI 1366086894 · ENGLISHTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 51 payments from 10 companies in 2025. Trend: 2023 $1,609 · 2024 $983 · 2025 $1,016
Food & beverage: $1,016
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $422 |
| Vanda Pharmaceuticals Inc. | 5 | $186 |
| ABBVIE INC. | 14 | $144 |
| Axsome Therapeutics, Inc. | 5 | $82 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Alkermes, Inc. | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: CAPLYTA, FANAPT, VRAYLAR, Auvelity, SPRAVATO, REXULTI, COBENFY, Jornay PM.
Industry payments across NJ — which companies pay providers there.
